Eli Lilly Shifts Alzheimer’s Research Funding to USC
Drugmaker Eli Lilly has announced that it will shift funding for Alzheimer's disease research from UC-San Diego to the University of Southern California. The move comes after a San Diego Superior Court judge ruled that UC-San Diego controls a major research project on Alzheimer's disease. USC has filed a countersuit for control of the nationwide cooperative study.
- "University of Southern California Gets Alzheimer's Funds" ("KPCC News," AP/KPCC, 8/5).